DK1150698T3 - Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion - Google Patents
Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktionInfo
- Publication number
- DK1150698T3 DK1150698T3 DK00904485T DK00904485T DK1150698T3 DK 1150698 T3 DK1150698 T3 DK 1150698T3 DK 00904485 T DK00904485 T DK 00904485T DK 00904485 T DK00904485 T DK 00904485T DK 1150698 T3 DK1150698 T3 DK 1150698T3
- Authority
- DK
- Denmark
- Prior art keywords
- subject
- growth factor
- vascular endothelial
- endothelial growth
- blood supply
- Prior art date
Links
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F27—FURNACES; KILNS; OVENS; RETORTS
- F27D—DETAILS OR ACCESSORIES OF FURNACES, KILNS, OVENS, OR RETORTS, IN SO FAR AS THEY ARE OF KINDS OCCURRING IN MORE THAN ONE KIND OF FURNACE
- F27D27/00—Stirring devices for molten material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Mechanical Engineering (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/234,591 US6706682B2 (en) | 1999-01-21 | 1999-01-21 | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1150698T3 true DK1150698T3 (da) | 2006-01-16 |
Family
ID=22882011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00904485T DK1150698T3 (da) | 1999-01-21 | 2000-01-21 | Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion |
Country Status (9)
Country | Link |
---|---|
US (2) | US6706682B2 (de) |
EP (1) | EP1150698B1 (de) |
JP (1) | JP2003501345A (de) |
AT (1) | ATE303818T1 (de) |
AU (1) | AU2623700A (de) |
CA (1) | CA2360058A1 (de) |
DE (1) | DE60022478T2 (de) |
DK (1) | DK1150698T3 (de) |
WO (1) | WO2000043029A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6706682B2 (en) * | 1999-01-21 | 2004-03-16 | The Trustees Of Columbia University In The City Of New York | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
AU7733800A (en) * | 1999-10-01 | 2001-05-10 | Duke University | A method of treating erectile dysfunction |
AU2001250821A1 (en) * | 2000-03-10 | 2001-09-24 | Chiron Corporation | Methods and compositions for the treatment and prevention of erectile dysfunction |
US7223406B2 (en) | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
EP1365794A2 (de) | 2000-07-21 | 2003-12-03 | Lue, Tom | Vorbeugung und behandlung von störungen der sexuellen erregbarkeit |
WO2007138590A2 (en) * | 2006-05-30 | 2007-12-06 | Yossi Gross | Implantable pump for drug delivery to treat erectile dysfunction |
US8152711B2 (en) * | 2007-03-21 | 2012-04-10 | Yossi Gross | Implantable peristaltic pump to treat erectile dysfunction |
US7818062B2 (en) * | 2008-01-31 | 2010-10-19 | Ed Tech Medical Ltd. | Peristaltic pump for treatment of erectile dysfunction |
US20120183519A1 (en) * | 2011-01-13 | 2012-07-19 | Biomet Biologics, Llc | Treatment of erectile dysfunction using platelet-rich plasma |
WO2016112049A1 (en) | 2015-01-06 | 2016-07-14 | Cardiovascular Biotherapeutics, Inc. | Angiogenic treatment of ischemic heart disease |
EP3259012A4 (de) * | 2015-02-16 | 2018-09-19 | CardioVascular BioTherapeutics, Inc. | Therapeutische angiogenese zur behandlung erektiler dysfunktionen |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236904A (en) | 1989-09-18 | 1993-08-17 | Senetek, Plc | Erection-inducing methods and compositions |
US5652225A (en) * | 1994-10-04 | 1997-07-29 | St. Elizabeth's Medical Center Of Boston, Inc. | Methods and products for nucleic acid delivery |
US5594032A (en) * | 1994-11-10 | 1997-01-14 | Gonzalez-Cadavid; Nestor F. | Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
EP1604674B1 (de) | 1998-05-01 | 2008-11-19 | University of Pittsburgh | Verwendung von Myoblasten zur Herstellung eines Medikaments zur Behandlung der stressbedingten Harninkontinenz |
EP1086494A4 (de) | 1998-05-15 | 2006-09-20 | Glaxo Group Ltd | Infrarotthermographie |
US6706682B2 (en) * | 1999-01-21 | 2004-03-16 | The Trustees Of Columbia University In The City Of New York | Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
AU7733800A (en) | 1999-10-01 | 2001-05-10 | Duke University | A method of treating erectile dysfunction |
-
1999
- 1999-01-21 US US09/234,591 patent/US6706682B2/en not_active Expired - Fee Related
-
2000
- 2000-01-21 AT AT00904485T patent/ATE303818T1/de not_active IP Right Cessation
- 2000-01-21 CA CA002360058A patent/CA2360058A1/en not_active Abandoned
- 2000-01-21 JP JP2000594482A patent/JP2003501345A/ja active Pending
- 2000-01-21 WO PCT/US2000/001535 patent/WO2000043029A1/en active IP Right Grant
- 2000-01-21 AU AU26237/00A patent/AU2623700A/en not_active Abandoned
- 2000-01-21 DK DK00904485T patent/DK1150698T3/da active
- 2000-01-21 DE DE60022478T patent/DE60022478T2/de not_active Expired - Fee Related
- 2000-01-21 EP EP00904485A patent/EP1150698B1/de not_active Expired - Lifetime
-
2003
- 2003-09-09 US US10/658,991 patent/US20040048800A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000043029A1 (en) | 2000-07-27 |
EP1150698A1 (de) | 2001-11-07 |
US20040048800A1 (en) | 2004-03-11 |
EP1150698A4 (de) | 2003-01-29 |
JP2003501345A (ja) | 2003-01-14 |
DE60022478D1 (de) | 2005-10-13 |
EP1150698B1 (de) | 2005-09-07 |
ATE303818T1 (de) | 2005-09-15 |
AU2623700A (en) | 2000-08-07 |
US20030124094A1 (en) | 2003-07-03 |
DE60022478T2 (de) | 2006-06-22 |
CA2360058A1 (en) | 2000-07-27 |
US6706682B2 (en) | 2004-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1150698T3 (da) | Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion | |
BR0112361A (pt) | Métodos para tratamento de condições oculares mediadas por inflamação | |
EA200001044A3 (ru) | Соединения для лечения женской сексуальной дисфункции | |
AU4077701A (en) | Agent for use in method of treatment | |
ATE256464T1 (de) | Verfahren zur bekämpfung infektiöser krankheiten unter verwendung dikationischer bis-benzimidazole | |
ATE229335T1 (de) | Heterozyklische bizykeln zur behandlung von impotenz | |
DE60045034D1 (de) | Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen | |
IS4100A (is) | Aðferð við meðhöndlun á ígræðlingi úr málmi fyrirskurðaðgerð | |
ATE369817T1 (de) | Vorrichtung zur abgabe von therapeutischen wirkstoffen | |
ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
NZ257484A (en) | Nucleotides active against tnf-alpha, treatment of viral diseases | |
AR024380A1 (es) | Tienopirimidinas | |
ATE453402T1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
EP1108426A3 (de) | Anwendung von Prostaglandinagonisten zur Behandlung der Erektionstörungen und Impotenz | |
DE69921008D1 (de) | Behandlung von Rückenmarkverletzungenbedingter Impotenz | |
DE69800859D1 (de) | Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen | |
ATE320270T1 (de) | Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren | |
ATE359798T1 (de) | Verwendungvon dextransulfat zur behandlung von ibmir | |
ATE291918T1 (de) | Kombinationstherapie zur behandlung von tumoren | |
WO2004024089A3 (en) | Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing | |
HUP0203486A2 (hu) | Véralvadással összefüggő betegségek megelőzése és kezelése | |
ATE183095T1 (de) | Verwendung von prostaglandin-e1 zur behandlung männlicher erektiler impotenz | |
ATE296631T1 (de) | Verwendung von pde5 inhibitoren zur behandlung vorzeitiger ejakulation | |
DK0900085T3 (da) | Behandling af overdreven aggression med olanzapin | |
UA32241A (uk) | Спосіб лікування запалювальних процесів у експериментальних тварин |